Exploring Advancements in Oncology with AstraZeneca’s Dr. Susan Galbraith
Thought Leader:
Dr. Susan Galbraith, SVP of Early Oncology, AstraZeneca
April 6, 2021
PharmaVOICE sat down with Dr. Susan Galbraith, SVP of Early Oncology, AstraZeneca, who disclosed her personal career journey with oncology and drug development as she works to improve patients’ lives.
